ArticleCancers2021

Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures.

Swetha Vasudevan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.